Patrick D. Yeramian, Chief Medical Officer: Amylyx Pharmaceuticals AMLX Sell · Filed 23/04/19

Trade details

Type: Insider sale
Amount: $1,504,487.87
Shares · price: 49,279 sh · $30.53 a share
Held after: 208,717 sh
Stock: Amylyx Pharmaceuticals AMLX
Person: Patrick D. YeramianChief Medical Officer
Trade date: 23/04/17
Filed: 23/04/19
Days to filing: 2 days

Sold 19.1% of holdings

Share of holding sold: 19.1%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/03/18~23/05/17

Patrick D. Yeramian's recent trades

Patrick D. YeramianChief Medical Officer
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$45.9K
2,812 sh
$45.9K
Filed 24/01/11
Traded 24/01/09
Patrick D. YeramianChief Medical Officer
Sell10b5-1 planAmylyx Pharmaceuticals
Sell10b5-1 plan
Amylyx Pharmaceuticals
AMLX
$347.3K
11,965 sh
$347.3K
Filed 23/05/17
Traded 23/05/15
Patrick D. YeramianChief Medical Officer
Sell10b5-1 planAmylyx Pharmaceuticals
Sell10b5-1 plan
Amylyx Pharmaceuticals
AMLX
$9,282
300 sh
$9,282
Filed 23/04/19
Traded 23/04/17
Patrick D. YeramianChief Medical Officer
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$1.7M
52,211 sh
$1.7M
Filed 23/03/24
Traded 23/03/16
Patrick D. YeramianChief Medical Officer
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$78.4K
2,416 sh
$78.4K
Filed 23/03/24
Traded 23/03/16